GIM
CAH icon

Glenmede Investment Management’s Cardinal Health CAH Stock Holding History

Glenmede Investment Management’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.95M Sell
12,419
-38,363
-76% -$5.93M 0.01% 567
2025
Q2 		$8.53M Buy
+50,782
New +$7.54M 0.04% 373

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glenmede Investment Management's CAH Position: Q3 2025 in Review

Glenmede Investment Management reduced its Cardinal Health (CAH) stake by 76% in Q3 2025, selling an estimated $5.93M and leaving 12,419 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #567.

Glenmede Investment Management first reported a position in CAH in Q2 2025 and has held it in 2 quarters since. The position peaked at $8.53M in Q2 2025. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Glenmede Investment Management held 12,419 shares of Cardinal Health worth $1.95M as of Q3 2025.
  • Glenmede Investment Management sold 38,363 Cardinal Health shares in Q3 2025, an estimated $5.93M.
  • Cardinal Health made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #567 holding.
  • Glenmede Investment Management first reported a position in Cardinal Health in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Cardinal Health position peaked at $8.53M in Q2 2025.
  • 1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.